Sanofi S.A.
Explore Sanofi
Core profile pages, annual revenue records, and related research hubs for this company.
Acquisitions
2
Total Acquisitions
2025
Added targeted medicines and pipeline depth.
Strengthened Sanofi's specialty-care and oncology-adjacent portfolio.
Integrated into Sanofi's focused biopharma strategy.
2011
Expanded Sanofi's rare disease and specialty medicine position.
Made rare diseases a deeper part of Sanofi's portfolio.
Genzyme became central to Sanofi's specialty-care identity.
The growth strategy centers on immunology, rare diseases, vaccines, pipeline productivity, selective business development, and a sharper focus after the Opella consumer-health separation path.
Sanofi makes money by discovering, developing, manufacturing, and selling prescription medicines and vaccines through direct sales teams, hospital channels, wholesalers, pharmacies, and government procurement programs. Major revenue drivers include specialty medicines such as Dupixent, rare disease therapies, vaccines, and established general medicines.